Telomir Pharmaceuticals Statistics
Total Valuation
TELO has a market cap or net worth of $44.87 million. The enterprise value is $38.57 million.
Important Dates
The last earnings date was Tuesday, March 17, 2026, after market close.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TELO has 34.38 million shares outstanding. The number of shares has increased by 7.16% in one year.
| Current Share Class | 34.38M |
| Shares Outstanding | 34.38M |
| Shares Change (YoY) | +7.16% |
| Shares Change (QoQ) | +3.38% |
| Owned by Insiders (%) | 14.83% |
| Owned by Institutions (%) | 6.66% |
| Float | 19.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.67 |
| P/TBV Ratio | 7.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.14, with a Debt / Equity ratio of 0.08.
| Current Ratio | 5.14 |
| Quick Ratio | 5.10 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -317.65% and return on invested capital (ROIC) is -184.93%.
| Return on Equity (ROE) | -317.65% |
| Return on Assets (ROA) | -152.03% |
| Return on Invested Capital (ROIC) | -184.93% |
| Return on Capital Employed (ROCE) | -178.22% |
| Weighted Average Cost of Capital (WACC) | 0.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.16M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.92% in the last 52 weeks. The beta is -0.65, so TELO's price volatility has been lower than the market average.
| Beta (5Y) | -0.65 |
| 52-Week Price Change | -70.92% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 1.46 |
| Relative Strength Index (RSI) | 48.24 |
| Average Volume (20 Days) | 80,488 |
Short Selling Information
The latest short interest is 1.44 million, so 4.19% of the outstanding shares have been sold short.
| Short Interest | 1.44M |
| Short Previous Month | 1.52M |
| Short % of Shares Out | 4.19% |
| Short % of Float | 7.57% |
| Short Ratio (days to cover) | 10.64 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.54M |
| Pretax Income | -10.41M |
| Net Income | -10.41M |
| EBITDA | n/a |
| EBIT | -10.54M |
| Earnings Per Share (EPS) | -$0.33 |
Full Income StatementBalance Sheet
The company has $7.29 million in cash and $473,752 in debt, with a net cash position of $6.81 million or $0.20 per share.
| Cash & Cash Equivalents | 7.29M |
| Total Debt | 473,752 |
| Net Cash | 6.81M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 5.91M |
| Book Value Per Share | 0.17 |
| Working Capital | 5.91M |
Full Balance SheetCash Flow
| Operating Cash Flow | -3.69M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 155,518 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
